IVF hartmann Holding AGXSWX:VBSN -0.79%74 PB Ratio is 1.93 as of Jun. 27, 2026, which is 30% below its 10-year median of 2.77. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.11 (Modestly Undervalued). Among 788 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 51.02% on this metric.
IVF hartmann Holding AG stock PB Ratio (=1.93) is close to 2-year low of 1.9.
The historical rank and industry rank for IVF hartmann Holding AG's PB Ratio or its related term are showing as below:
XSWX:VBSN'
s PB Ratio Range Over the Past 10 Years
Min: 1.63 Med: 2.77 Max: 5.5
Current: 1.93
During the past 13 years, IVF hartmann Holding AG's highest PB Ratio was 5.50. The lowest was 1.63. And the median was 2.77.
XSWX:VBSN's PB Ratio is ranked better than 51.02% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs XSWX:VBSN: 1.93
During the past 12 months, IVF hartmann Holding AG's average Book Value Per Share Growth Rate was 3.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of IVF hartmann Holding AG was 15.60% per year. The lowest was 2.80% per year. And the median was 7.00% per year.
Back to Basics: PB Ratio
IVF hartmann Holding AG (XSWX:VBSN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
IVF hartmann Holding AG (XSWX:VBSN) has a PB Ratio of 1.93 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on IVF hartmann Holding AG and its competitors. This is 30% below median its historical median of 2.77. Over the past decade, IVF hartmann Holding AG's PB Ratio has ranged from 1.63 to 5.50. According to the industry distribution chart, IVF hartmann Holding AG ranks #386 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 49%.
Is IVF hartmann Holding AG's PB Ratio too high?
IVF hartmann Holding AG's current PB Ratio of 1.93 is 30% below median its 10-year median of 2.77. Over the past 10 years, this metric has ranged from a low of 1.63 to a high of 5.50. The Medical Devices & Instruments industry median PB Ratio is 2.02. IVF hartmann Holding AG's value of 1.93 is 4.5% below this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #386 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #386 out of 788 companies for PB Ratio. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median PB Ratio is 2.02. IVF hartmann Holding AG's value of 1.93 is 4.5% below this benchmark. Historically, IVF hartmann Holding AG's own PB Ratio has ranged from 1.63 to 5.50 over the past decade. While the company's 10-year median is 2.77 vs. the industry median of 2.02, IVF hartmann Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current PB Ratio of 1.93 is 4.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current PB Ratio is 1.93, which is 30% below median its own 10-year median of 2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.11, compared to a current price of CHF126.00 — trading 12% below its estimated fair value. The current PB Ratio is 1.93, which is 30% below median its 10-year median of 2.77 and 4.5% below the Medical Devices & Instruments industry median of 2.02. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current PB Ratio is 1.93 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF126.00 is trading 12% below its estimated GF Value™ of CHF143.11.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
PB Ratio: 1.93 (30% below median its 10-year median of 2.77)
GF Value™: CHF143.11 vs. price of CHF126.00 (12% below fair value)
Industry Position: 4.5% below the Medical Devices & Instruments median (#386 of 788)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
